Which set of routes is associated with variable onset and moderate control?

• A. Oral, Sublingual, Rectal, Intranasal
• B. IV, IM
• C. Topical
• D. Inhalation

Answer: (A)

Understanding how a drug enters the body helps explain why onset and dosing control vary by route. The gut and the nasal/other mucosal surfaces absorb drugs at different rates, and some routes pass through the liver before reaching systemic circulation, all of which affects how quickly and predictably a drug acts.

Oral administration goes through the digestive system and encounters first-pass metabolism in the liver, making absorption slow and highly variable. Because of this, you can see a wide range of onset times and less precise dosing — a hallmark of variable onset with only moderate control.

Sublingual dosing dissolves under the tongue and largely bypasses the liver, so the onset is faster and more predictable than oral. However, it still depends on factors like how quickly the tablet dissolves and how long it stays in contact with the mucosa, so it’s not perfectly uniform—leading to moderate control rather than the tight control of injections.

Rectal absorption can be inconsistent due to stool contents, mucosal condition, and venous drainage patterns, yielding variable onset with moderate dosing control.

Intranasal delivery uses the nasal mucosa for absorption and can act quickly, but absorption can vary with nasal congestion, mucous thickness, and irritation, producing variable timing with only moderate control.

In contrast, routes like intravenous or intramuscular injections typically provide rapid onset with high control, and topical routes tend to have local effects with slower or unpredictable systemic absorption. The group described here is the one most associated with variable onset and moderate control.